ACT CAPITAL MANAGEMENT, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2022$241,000
-18.9%
330,0000.0%0.33%
-19.8%
Q2 2022$297,000
-39.6%
330,0000.0%0.42%
-20.3%
Q1 2022$492,000
-31.3%
330,0000.0%0.52%
+0.6%
Q4 2021$716,000
-39.1%
330,0000.0%0.52%
-14.9%
Q3 2021$1,175,000
-38.0%
330,0000.0%0.61%
-37.5%
Q2 2021$1,895,000330,0000.97%
Other shareholders
ONCOCYTE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders